Actively Recruiting
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
Led by Anhui Provincial Hospital · Updated on 2025-08-01
600
Participants Needed
3
Research Sites
21 weeks
Total Duration
On this page
Sponsors
A
Anhui Provincial Hospital
Lead Sponsor
T
The First Affiliated Hospital of Soochow University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The current study aims to develop and validate a deep learning signature for diagnosing pathology and predicting prognosis of lung nodule using smartphone photos of resected tumor specimens.
CONDITIONS
Official Title
Artificial Intelligence for Pathology Diagnosis and Prognosis Prediction of Lung Nodule Using Smartphone Photos
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for surgery for lung lesions found by preoperative thin-section CT scans
- Between 20 and 75 years old
You will not qualify if you...
- Incomplete clinical information
- Received anti-tumor therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Anhui Provincial Hospital
Hefei, Anhui, China, 230000
Actively Recruiting
2
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215000
Actively Recruiting
3
Ningbo First Hospital
Ningbo, Zhejiang, China, 315000
Actively Recruiting
Research Team
Y
Yifan Zhong, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here